Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Cost-Effective Method Detects Chikungunya virus

By LabMedica International staff writers
Posted on 05 Aug 2013
The use of capillary blood samples blotted on filter papers for molecular diagnosis of Chikungunya virus (CHIKV) infection has been evaluated. More...


Venous blood samples can be difficult to obtain for the diagnosis of CHIKV and the shipment of serum in appropriate temperature conditions is too costly for most developing countries.

Scientists at the Institut Pasteur de Madagascar (Antananarivo, Madagascar) collected samples from all patients, visiting sentinel centers, that fulfilled the case definition for dengue-like illness with onset within the previous five days were included in the study. Both venous blood and capillary blood were collected and spotted onto a clean Whatman 3MM filter paper (Sigma-Aldrich; St. Louis, MO, USA).

All samples were tested by real-time polymerase chain reaction (RT-PCR) and results with serum and dried-blood blotted on filter paper (DBFP) samples were compared for each patient. CHIKV ribonucleic acid (RNA) was detected by one-step real-time RT-PCR assays in a Rotorgene 6000 apparatus (Corbett Life Science; Mortlake, NSW, Australia; www.corbettlifescience.com).


Overall, 181 samples from patients presenting dengue-like illness were included in the study: 73 (40.3%) were CHIKV confirmed cases and 108 (59.7%) were negative controls; the median age was 18 years and 32 years, and sex ratio (M/F) were 1.2 and 0.5, respectively. Among the 181 patients tested, DBFP for 74 (40.9%) and sera for 73 (40.3%) scored positive for CHIKV. The sensitivity and specificity of tests performed with DBFP were very similar to those with venous samples. The loss of sensitivity was insignificant and involved a very small number of patients, all with low viral loads.

The authors concluded that DBFP is a cost-effective method for surveillance and for the monitoring of viral outbreaks in low-income countries, and especially in large countries where the access to laboratory facilities is limited. This method can facilitate the extension of surveillance system networks, and may be useful to public health authorities for rapid identification of Chikungunya outbreaks and, by extension, those of other arboviruses, such as Dengue fever, Rift Valley Fever, West Nile. The study was published on July 25, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Institut Pasteur de Madagascar
Sigma-Aldrich
Corbett life science




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.